Hashimoto, Yosuke
Greene, Chris
Munnich, Arnold
Campbell, Matthew
Funding for this research was provided by:
European Research Council (864522)
Science Foundation Ireland (SFI/TCD 21/SPP/3732)
Article History
Received: 9 January 2023
Accepted: 14 March 2023
First Online: 28 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: Trinity College Dublin owns a patent portfolio related to the use of RNA interference to target claudin-5 for BBB modulation.